<p>Jason Karlawish is a Professor of Medicine, Medical Ethics and Health Policy, and Neurology at the <a href="http://medicalethics.med.upenn.edu/&quot; target="_blank">University of Pennsylvania</a>.</p> <p>He cares for patients at the <a href="https://pennmemorycenter.org/&quot; target="_blank">Penn Memory Center</a>, which he co-directs,&nbsp;and directs the Neurodegenerative Disease Ethics and Policy Program and the Penn Healthy Brain Research Center.</p><p>With support from the National Institutes of Health, the Robert Wood Johnson Foundation and the Greenwall Foundation, he has investigated the development of Alzheimer’s disease treatments and diagnostics, biomarker-based concepts of disease, informed consent, quality of life, research and treatment decision making, and voting by persons with cognitive impairment and residents of long term care facilities. He has been an international proponent of mobile polling, a method of bringing the vote to long term care facilities that minimizes fraud and maximizes voter rights. He is a winner of the <em>Lancet's</em> <a href="https://pubmed.ncbi.nlm.nih.gov/9454054/&quot; target="_blank">Wakley Prize</a>. In 2010, in a widely publicized essay in the <em>Journal of the American Medical Association, </em>he introduced the concept of “<a href="https://jamanetwork.com/journals/jama/fullarticle/186858&quot; target="_blank">desktop medicine</a>,” a theory of medicine that recognizes how risk and its numerical representations are transforming medicine, medical care, and healt</p>